Bangladesh's leading listed pharmaceutical companies have bagged higher profits in the first half of the current financial year which began in July 2020, a result of people starting to see doctors again.

Despite the November to January period being a slow season from the usual business perspective, there was a year-on-year jump in profit growth in the six months.

Profits rose for all six drug makers who have published their financial reports.

For Square Pharmaceuticals, it was 12.79 per cent to Tk 776 crore. It had also witnessed higher profits in the preceding six months amid the coronavirus pandemic.